[{"indications": "Indications\u00a0iron poisoning; chronic\r\niron overload (section 9.1.3)", "name": "DESFERRIOXAMINE MESILATE - IRON SALTS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "Emergency treatment of poisoning", "Specific drugs", "Iron salts"], "cautions": "Cautions\u00a0section 9.1.3", "side-effects": "Side-effects\u00a0section\r\n9.1.3", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/29544.htm", "doses": ["By continuous intravenous infusion, adult and child up\r\nto 15\u00a0mg/kg/hour, reduced after 4\u20136 hours; max. 80\u00a0mg/kg in 24 hours\r\n(in severe cases, higher doses on advice from the National Poisons\r\nInformation Service)"], "pregnancy": "Pregnancy\u00a0section 9.1.3"}, {"indications": "Indications\u00a0iron poisoning; chronic\r\niron overload (section 9.1.3)", "name": "DESFERRIOXAMINE MESILATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "Emergency treatment of poisoning", "Specific drugs", "Iron salts"], "cautions": "Cautions\u00a0section 9.1.3", "side-effects": "Side-effects\u00a0section\r\n9.1.3", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/29544.htm", "doses": ["By continuous intravenous infusion, adult and child up\r\nto 15\u00a0mg/kg/hour, reduced after 4\u20136 hours; max. 80\u00a0mg/kg in 24 hours\r\n(in severe cases, higher doses on advice from the National Poisons\r\nInformation Service)"], "pregnancy": "Pregnancy\u00a0section 9.1.3"}, {"indications": "Indications\u00a0\n(From Iron overload: British National Formulary)\nIron overload; iron poisoning, \n(From Iron salts: British National Formulary)\nIron salts", "name": "DESFERRIOXAMINE MESILATE - IRON OVERLOAD", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.1 Anaemias and some other blood disorders", "9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias", "Iron overload", "DESFERRIOXAMINE MESILATE"], "cautions": "Cautions\u00a0eye and ear examinations before treatment and at 3-month intervals\r\nduring treatment; monitor body-weight and\r\nheight in children at 3-month intervals\u2014risk of growth retardation\r\nwith excessive doses; aluminium-related\r\nencephalopathy (may exacerbate neurological dysfunction); interactions: Appendix 1 (desferrioxamine)", "side-effects": "Side-effects\u00a0nausea, vomiting, abdominal pain; headache; pyrexia;\r\ngrowth retardation and bone disorders (see Cautions); arthralgia,\r\nmyalgia; hearing disturbances; injection-site reactions; rarely diarrhoea, hepatic impairment, hypotension (especially when given\r\ntoo rapidly by intravenous injection), anaphylaxis, Yersinia and mucormycosis\r\ninfections, blood dyscrasias (including thrombocytopenia and leucopenia),\r\nleg cramps, bone pain,  visual disturbances (including lens opacity\r\nand retinopathy), rash; very rarely acute respiratory\r\ndistress, neurological disturbances (including dizziness, neuropathy,\r\nconvulsions, and paraesthesia), renal impairment; muscle spasms also\r\nreported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/128327.htm", "doses": ["See notes above; iron poisoning, see Emergency Treatment of Poisoning", "For full details and warnings relating to\r\nadministration, consult product literature"], "pregnancy": "Pregnancy\u00a0teratogenic in animal studies; manufacturer\r\nadvises use only if potential benefit outweighs risk"}]